MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Appoints First Chief Commercial Officer Ahead of Ketamine Launch April 14, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by financialcontent. Read more Source: https://www.financialcontent.com/article/nnwire-2026-4-13-missionirnewsbreaks-nrx-pharmaceuticals-inc-nasdaq-nrxp-appoints-first-chief-commercial-officer-ahead-of-ketamine-launch
